fig1

Clinical applications and advances in noninvasive prognostic assessment of metabolic dysfunction-associated steatotic liver disease

Figure 1. The sequential approach in MASLD. Created with BioGDP.com[105]. *FIB-4 thresholds are recommended by clinical practice guidelines[106,107]; VCTE thresholds are recommended by clinical practice guidelines[106,107]. ELF and MRE thresholds are exploratory values derived from meta-analyses and cohort studies[108-110]. MASLD: Metabolic dysfunction-associated steatotic liver disease; FIB-4: Fibrosis-4 index; AST: aspartate aminotransferase; ALT: alanine aminotransferase; VCTE: vibration-controlled transient elastography; ELF: enhanced liver fibrosis; MRE: magnetic resonance elastography.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/